No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Instruments & Supplies
Eye Bright Medical Technology Co., Ltd., established in 2010 in Beijing, China, specializes in crafting a diverse array of ophthalmic medical solutions. The company's extensive product line is geared towards addressing various ocular conditions and visual impairments, encompassing surgical implants, specialized instruments, and diagnostic equipment, as well as optometric lenses and pharmaceutical eye drops. These innovations are developed to provide treatment for a range of eye diseases, notably cataracts, glaucoma, and refractive errors, among other ophthalmic issues.
www.ebmedical.comNo one on the platform currently holds 688050.SS.
No tracked institution reports a position in 688050.SS as of their last filing.
No one on the platform has traded 688050.SS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 9.7% | 12.9% | — | — | — | |
| Rev. Growth % | 5.2% | 40.3% | ||||
| Profit Margin % | 18.1% | 31.5% | 23.4% | |||
| Free Cash Flow Margin % | 16.6% | -4.7% | -20.8% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $1.9B | +20.0% | $1.80 | $1.72–$1.91 | — | 2 |
| 2027 | $2.1B | +14.1% | $2.15 | $2.06–$2.29 | — | 3 |
| 2028 | $2.4B | +13.0% | $2.52 | $2.26–$2.80 | — | 5 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 3 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-26 | $0.48 | $0.49 | +0.8% |
| 2026-04-22 | $0.53 | $0.47 | -12.1% |
| 2026-04-22 | $0.24 | $-0.11 | -147.4% |
| 2025-10-29 | $0.64 | $0.41 | -36.0% |
| 2025-08-27 | $0.64 | $0.35 | -45.3% |
| 2025-04-22 | $0.72 | $0.49 | -32.2% |
| 2025-02-06 | $0.37 | $0.37 | +1.3% |
| 2024-10-29 | $0.57 | $0.58 | +1.8% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 688050.SSEyebright Medical Technology (Beijing) Co., Ltd. | $37.79 | +1.45% | $7.3B | — |
| 000028.SZChina National Accord Medicines Corporation Ltd. | $19.74 | -0.30% | $10.5B | — |
| 002626.SZXiamen Kingdomway Group Company | $16.13 | -0.06% | $9.8B | — |
| 300171.SZTofflon Science and Technology Group Co., Ltd. | $13.71 | -0.29% | $10.4B | — |
| 300595.SZAutek China Inc. |
| $9.95 |
| +0.51% |
| $8.9B |
| — |
| 600993.SSMayinglong Pharmaceutical Group Co., Ltd. | $22.37 | +0.18% | $9.6B | — |
| 603883.SSLBX Pharmacy Chain Joint Stock Company | $12.65 | -1.25% | $9.6B | — |
Source: Financial Modeling Prep · peers by sector/industry